Skip to content
DataLookout
Menu

NCT07900945

Study of Single and Multiple Ascending Doses of CM551 in Healthy Participants

StatusNot Yet Recruiting
PhasePhase 1
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 1 version: 1 with changes below.

  1. Study First Submitted

Endpoints

Primary

Incidence of Treatment-Emergent Adverse Events
Timeframe: through study completion, an average of 1.5 years

Arms and interventions

SAD Cohorts 1~4 Experimental ArmExperimental
SAD Cohorts 1~4 Placebo ArmPlacebo comparator
MAD Cohorts 5~6 Experimental ArmExperimental
MAD Cohorts 5~6 Placebo ArmPlacebo comparator

Biologicals: CM551

Drugs: Placebo

Sites

1 site in 1 country

  • Tianjin Medical University General HospitalTianjin, Tianjin Municipality, China